Introduction
Introduction Statistics Contact Development Disclaimer Help
Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
MS Speaks
*****************************************************
(Abst.) Shorter infusion time of ocrelizumab...
1 replies
(ACTRIMS/ECTRIMS) Some MS drugs linked with worse COVID-19 out...
0 replies
(Abst.) Effect of Ocrevus on vaccine responses in patients w/MS
0 replies
(Abst.) Adverse event profile differences between Rituxan and ...
1 replies
(Abst.) Varicella zoster immunity loss in MS patient treated w...
0 replies
(Abst.) Switching to Ocrevus in RRMS patients at risk of PML p...
0 replies
2-hour Ocrevus infusion time OK'd in Europe
0 replies
1st PML case with ocrelizumab alone reported
2 replies
Ocrelizumab approved for "early PPMS" in Scotland
0 replies
(Abst.) Two meningitis cases associated with ocrelizumab therapy
0 replies
*****************************************************
Previous Page
Next Page
You are viewing proxied material from gopher.createaforum.com. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.